This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The online marketplace PartnerSlate has made waves in the food and beverage contractmanufacturing industry, recently securing a $4 million investment to further its mission of connecting food brands and contractmanufacturers. This is where San Francisco-based PartnerSlate comes in.
International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.
The global antibodies contractmanufacturingmarket is expected to reach from USD 13.4 billion in 2022 to USD 35.9 billion by 2030, registering a CAGR of 13.1% from 2022 to 2030. Rise in demand for the production of therapeutic antibodies … Continue reading →
Given such technical and operational challenges associated with the production of RNA-based products, innovators in the biopharmaceutical industry are increasingly relying on the contractmanufacturing service providers to cater to the urgent global demand.
Pharma ContractManufacturing: From the pharmaceutical sector there is a group of businesses that have tasked themselves to assist other businesses to provide better solutions to customers. When a contractmanufacturing company wakes up with a customer in the business, the customer cannot control the jobs the CMO is in control of.
Biopharmaceutical ContractManufacturingMarket, 2030 – ResearchAndMarkets.com Biopharmaceutical ContractManufacturingMarket, 2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Biopharmaceutical ContractManufacturingMarket by Type of Product, Scale of Operations, Expression System, Company Size, Biologics and (..)
Pharmaceutical drug research and development (R&D) activities are capital-intensive, which makes the outsourcing of clinical dose manufacturing and marketing popular. Find the leading clinical dose companies in contractmarketing. Prospects of clinical dose companies in contractmarketing.
Owing to the incessant demand for oligonucleotide-based products, several small to mid-sized companies and certain pharma giants, have begun outsourcing their manufacturing operations to contract service providers. Oligonucleotide Synthesis, Modification and Purification Services Market. Our Social Media Platform. Web: [link].
The growing demand for innovative drugs and a limited number of blockbuster drugs has led to the growth of the pharmaceutical contractmanufacturingmarket, which has fuelled contract commercial dose manufacturing and marketing. Discover the leading commercial dose companies in contractmarketing.
Torbay Pharmaceuticals is a sterile injectable contractmanufacturer and licence holder based in Devon, UK. We spoke with CEO Emma Rooth about the company's heritage and how it is striving to support the U.S.
Pharmaceutical solid dose manufacturing companies in contractmarketing segment have gained a vital position in pharmaceutical formulations. Find the leading pharmaceutical solid dose manufacturing companies in contractmarketing.
Global Pharmaceutical ContractManufacturing and Research Services Market Analysis Report 2021-2028 – ResearchAndMarkets.com Global Pharmaceutical ContractManufacturing and Research Services Market Analysis Report 2021-2028 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical ContractManufacturing (..)
4th Edition Market Study into Small Molecule Drug Product ContractManufacturer Quality – ResearchAndMarkets.com 4th Edition Market Study into Small Molecule Drug Product ContractManufacturer Quality – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Small Molecule Drug Product ContractManufacturer Quality Benchmarking (..)
Regenxbio says it is to delay dosing of patients in its DMD gene therapy clinical trial following a quality issue at an unnamed third-party contractmanufacturer.
LONDON–(BUSINESS WIRE)–#marketintelligence–The Pharmaceutical ContractManufacturingmarket size is expected to grow over USD 30 billion at a Compound Annual Growth Rate (CAGR) of 6.0% This increasing spend on pharmaceutical contractmanufacturing services will be … Continue reading →
As a result, biopharmaceutical contractmanufacturing has picked up pace in the recent years. Currently, a significant number of players engaged in the biopharmaceutical domain prefer to outsource various operations to contract service providers. The same is true for the biopharmaceutical contract services market.
Pharmaceutical ContractManufacturing Industry Mergers and Acquisitions – 2021 Market Implications and Outlook Report – ResearchAndMarkets.com Pharmaceutical ContractManufacturing Industry Mergers and Acquisitions – 2021 Market Implications and Outlook Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Mergers (..)
As a result, biopharmaceutical contractmanufacturing has picked up pace in the recent years. Currently, a significant number of players engaged in the biopharmaceutical domain prefer to outsource various operations to contract service providers. The same is true for the biopharmaceutical contract services market.
Global Pharmaceutical ContractManufacturing Organization Market Growth, Trends and Forecasts 2021-2026: A $195.70 Billion Market by 2026 – ResearchAndMarkets.com Global Pharmaceutical ContractManufacturing Organization Market Growth, Trends and Forecasts 2021-2026: A $195.70
Vaccine ContractManufacturing Global Market Forecast to Record Compound Annual Growth of 9% Between 2021-2026 – ResearchAndMarkets.com Vaccine ContractManufacturing Global Market Forecast to Record Compound Annual Growth of 9% Between 2021-2026 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Vaccine ContractManufacturing (..)
Global Biologic API ContractManufacturer 2020 Market – Featuring Abbvie, Boehringer Ingelheim and Catalent Among Others – ResearchAndMarkets.com Global Biologic API ContractManufacturer 2020 Market – Featuring Abbvie, Boehringer Ingelheim and Catalent Among Others – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The (..)
Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are generally associated with high costs of development and complex manufacturing protocols. Advanced and complex technologies are required for manufacturing, as well as testing of biopharmaceuticals.
DUBLIN–(BUSINESS WIRE)–The “Vaccine ContractManufacturingMarket Research Report by Function, by Applications – Global Forecast to 2025 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.
North America Pharmaceutical ContractManufacturingMarket 2021-2026: Growth, Trends, COVID-19 Impact, and Forecasts – Market is Expected to Reach $62.04
Global Pharmaceutical ContractManufacturingMarket 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com Global Pharmaceutical ContractManufacturingMarket 2021-2026: Increasing Focus on Specialty Drugs and Attractive Nuclear Medicine Sector – ResearchAndMarkets.com DUBLIN–(BUSINESS (..)
Insights on the Vaccine ContractManufacturing Global Market to 2027 – Featuring Ajinomoto Althea, Catalent and IDT Biologika Among Others – ResearchAndMarkets.com Insights on the Vaccine ContractManufacturing Global Market to 2027 – Featuring Ajinomoto Althea, Catalent and IDT Biologika … Continue reading →
The increasing investment in pharmaceutical research and development, and the growing adoption of contractmanufacturing and marketing practices are driving the demand for clinical trial contract packaging solutions. Finding the best clinical trial packaging services providers.
Outlook on the Biologics ContractManufacturing Global Market to 2031 – Focus on Monoclonal Antibodies, Recombinant Proteins, Vaccines and Molecular Therapy – ResearchAndMarkets.com Outlook on the Biologics ContractManufacturing Global Market to 2031 – Focus on Monoclonal Antibodies, Recombinant Proteins, … Continue reading (..)
The current landscape consists of more than 95 players that claim to offer oligonucleotide contractmanufacturing services for research, diagnostic and therapeutic applications. These contract service providers are actively entering into strategic collaborations to augment their existing portfolios. Our Social Media Platform.
North American Pharmaceutical ContractManufacturingMarkets Report 2021-2027: Manufacturing Services, Non-Clinical Services Such As Supply Chain Management, Research& Development – ResearchAndMarkets.com North American Pharmaceutical ContractManufacturingMarkets Report 2021-2027: Manufacturing Services, Non-Clinical Services Such As Supply (..)
Novo Nordisk is maintaining a strong market position in the glucagon-like peptide-1 receptor agonist (GLP-1RA) market, despite the launch of the dual agonist GLP-1RA/gastric inhibitory peptide (GLP-1RA/GIP) from its main competitor in the diabetes market, Eli Lilly.
Even giant pharma companies with large internal production capabilities are leaning on outsourcing to meet market demand for huge numbers of injectables, including high-value biologics and Covid-19 vaccines, according to a GlobalData analysis.
Contract development and manufacturing organizations (CDMOs) perform vital services for the biopharmaceutical industry â a role that is growing as cell and gene therapies gain momentum. Here are five of the top CDMOs bringing advanced therapies toward the market.
As capital project delivery ramps back up to pre-pandemic levels over the coming months and years, the smaller biopharma players are looking outside their own resources for strategic manufacturing and research support, confirms a new market outlook from CRB.
In preparation for this, drug manufacturing will begin later this year and will be outsourced to external contractmanufacturing organisations (CMOs). The most common marketed drugs in this space aim to address the hyperammonaemia caused by the defective genes in this disorder.
Despite China producing a significant proportion of the world’s API supply (mostly small molecule), it manufactures relatively few biosimilar and innovator drugs and no cell and gene therapies for the western markets of Europe and the US despite investments and an increasing number of startups to improve innovative manufacture.
With over 18 years of experience, Alexander Dragitsch is a commercial customer service contractmanufacturing (CSCM) manager at Baxter’s Halle/Westfalen facility in Germany. Alex and his team have the significant responsibility of managing various commercial programs for more than 40 marketed products.
In the last year, well-known contractmanufacturing organisations (CMOs) such as Agilent Technologies (Santa Clara, California) and Abzena (Cambridge, UK) have expanded their continuous manufacturing capabilities. US Congress is also making substantial investments to improve the continuous manufacturing of pharmaceuticals.
Alkindi is one of EffRx’s three marketed drugs. The biotech transferred the rights for alendronate to Merck which marketed the drug under the brand name Vancapsi. Separate from drug development, the Italian company also offers contractmanufacturing and clinical supply services.
Ahead of CPHI North America, we caught up with Lisa Stiles, director, business development at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.
Role of nanoparticles has been well established across various markets, such as healthcare, paint, consumer products ( including sunscreens, cosmetics ), aerospace and glass industries. Hence, many pharmaceutical companies outsource manufacturing of nanoparticles to third party organizations, called as contractmanufacturers.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content